Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 4,812
Out of 4,820 analysts
18
Total ratings
8.33%
Success rate
-41.72%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI Atai Life Sciences | Initiates: Buy | $18 | $1.45 | +1,141.38% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $14.67 | +15.88% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $3.87 | +778.55% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $107.25 | -11.42% | 2 | Nov 1, 2022 | |
| SAGE Sage Therapeutics | Initiates: Hold | $41 | $7.78 | +426.99% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $0.72 | +176.28% | 2 | May 20, 2022 | |
| ATHA Athira Pharma | Initiates: Buy | $33 | $0.27 | +12,077.12% | 1 | Apr 21, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $1.76 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $2.77 | +1,057.32% | 4 | Dec 16, 2020 |
Atai Life Sciences
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $1.45
Upside: +1,141.38%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $14.67
Upside: +15.88%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $3.87
Upside: +778.55%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $107.25
Upside: -11.42%
Sage Therapeutics
Nov 1, 2022
Initiates: Hold
Price Target: $41
Current: $7.78
Upside: +426.99%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $0.72
Upside: +176.28%
Athira Pharma
Apr 21, 2022
Initiates: Buy
Price Target: $33
Current: $0.27
Upside: +12,077.12%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $1.76
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $2.77
Upside: +1,057.32%